Blar i Institutt for klinisk og molekylær medisin på tidsskrift "Annals of Oncology"
Viser treff 1-2 av 2
-
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
(Peer reviewed; Journal article, 2023)Background We aim to implement an immune cell score model in routine clinical practice for resected non-small-cell lung cancer (NSCLC) patients (NCT03299478 ). Molecular and genomic features associated with immune ... -
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
(Peer reviewed; Journal article, 2020)Background The antitumor efficacy of PARP inhibitors (PARPi) for breast cancer patients harboring germline BRCA1/2 (gBRCA1/2) mutations is well established. While PARPi monotherapy was ineffective in patients with metastatic ...